Volpara takeover by Lunit gets tick from Grant Samuel

Volpara takeover by Lunit gets tick from Grant Samuel
A technician uses Volpara's system to screen for breast cancer. (Image: Getty)
Pattrick Smellie
Directors in Wellington-headquartered health-tech firm Volpara are recommending shareholders accept a 100% takeover bid from a Korean-listed counterpart after a favourable independent valuation.ASX-listed Volpara was judged by independent valuer Grant Samuel to be worth between A67c (72c) and A82c per share, compared with the takeover from Seoul-based Lunit pitched at A$1.15.The offer represented a 47% premium to the A87cps that Volpara was trading at before the Lunit bid on Dec 14, and 55% above the weighted average share price in the month be...

More Markets

THL buyout offer lifts NZX 50
Markets Market Close

THL buyout offer lifts NZX 50

Tourism Holdings helped the NZX 50 rise 1.09%.

Gregor Thompson 16 Jun 2025
THL exec enlists private equity for takeover bid
Markets

THL exec enlists private equity for takeover bid

In tandem with the offer, the consortium has amassed a 19.99% stake in THL.

Gregor Thompson 16 Jun 2025
Comvita forecasts another annual loss
Markets

Comvita forecasts another annual loss

Forecast losses don't include any impairment which is likely to be significant.

Staff reporters 16 Jun 2025
NZ sharemarket ends lower, spike in oil prices
Markets Market Close

NZ sharemarket ends lower, spike in oil prices

Australian, Hong Kong and Japanese share markets were all down after the attack.

Jamie Gray 13 Jun 2025